Sensus Healthcare, Inc. (NASDAQ:SRTS) Short Interest Up 20.0% in December

Sensus Healthcare, Inc. (NASDAQ:SRTS) was the target of a significant increase in short interest in December. As of December 15th, there was short interest totalling 583,500 shares, an increase of 20.0% from the November 30th total of 486,100 shares. Based on an average daily volume of 174,600 shares, the days-to-cover ratio is presently 3.3 days. Currently, 4.4% of the company’s stock are short sold.

Institutional Trading of Sensus Healthcare

Institutional investors have recently bought and sold shares of the company. Geode Capital Management LLC raised its holdings in Sensus Healthcare by 8.5% in the third quarter. Geode Capital Management LLC now owns 146,404 shares of the company’s stock worth $849,000 after buying an additional 11,525 shares during the last quarter. XTX Topco Ltd raised its holdings in Sensus Healthcare by 76.0% in the 3rd quarter. XTX Topco Ltd now owns 31,530 shares of the company’s stock worth $183,000 after acquiring an additional 13,619 shares during the last quarter. Truvestments Capital LLC bought a new position in Sensus Healthcare in the 3rd quarter valued at approximately $32,000. Cubist Systematic Strategies LLC bought a new position in Sensus Healthcare in the 2nd quarter valued at approximately $156,000. Finally, Marshall Wace LLP boosted its stake in Sensus Healthcare by 152.4% during the 2nd quarter. Marshall Wace LLP now owns 77,387 shares of the company’s stock valued at $412,000 after purchasing an additional 46,732 shares during the last quarter. 25.30% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of analysts have recently commented on SRTS shares. Maxim Group boosted their target price on shares of Sensus Healthcare from $12.00 to $14.00 and gave the company a “buy” rating in a report on Friday, November 15th. HC Wainwright upped their price objective on shares of Sensus Healthcare from $10.00 to $11.00 and gave the stock a “buy” rating in a report on Monday, November 18th.

Sensus Healthcare Trading Down 0.6 %

NASDAQ SRTS opened at $7.17 on Tuesday. Sensus Healthcare has a 12 month low of $2.36 and a 12 month high of $9.33. The stock’s fifty day moving average price is $7.62 and its 200-day moving average price is $6.58. The stock has a market cap of $117.51 million, a P/E ratio of 12.58 and a beta of 1.16.

About Sensus Healthcare

Sensus Healthcare, Inc, a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters.